While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...
Aubagio remains one of Sanofi's biggest-selling drugs, bringing in more than €2 billion last year, although its growth has slowed due to increasing competition in the marketplace.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback